VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
+0.85%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
AUM
$191M
AUM Growth
-$20.5M
Cap. Flow
-$11.9M
Cap. Flow %
-6.22%
Top 10 Hldgs %
8%
Holding
450
New
8
Increased
100
Reduced
215
Closed
125
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
HARP
226
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$297K 0.16%
1,748
-238
-12% -$40.4K
EFR
227
Eaton Vance Senior Floating-Rate Fund
EFR
$343M
$296K 0.16%
25,446
-7,352
-22% -$85.5K
MCI
228
Barings Corporate Investors
MCI
$434M
$296K 0.16%
23,711
-2,777
-10% -$34.7K
KRYS icon
229
Krystal Biotech
KRYS
$4.35B
$295K 0.15%
6,846
-938
-12% -$40.4K
SNDX icon
230
Syndax Pharmaceuticals
SNDX
$1.47B
$294K 0.15%
19,894
-2,702
-12% -$39.9K
DCPH
231
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$291K 0.15%
5,678
-781
-12% -$40K
MRSN icon
232
Mersana Therapeutics
MRSN
$34M
$288K 0.15%
619
-84
-12% -$39.1K
ALLO icon
233
Allogene Therapeutics
ALLO
$255M
$287K 0.15%
7,611
-1,039
-12% -$39.2K
OCSL icon
234
Oaktree Specialty Lending
OCSL
$1.23B
$286K 0.15%
19,724
-8,045
-29% -$117K
RNAC icon
235
Cartesian Therapeutics
RNAC
$277M
$285K 0.15%
3,834
-523
-12% -$38.9K
XENE icon
236
Xenon Pharmaceuticals
XENE
$3.02B
$284K 0.15%
25,673
-3,497
-12% -$38.7K
BTAI icon
237
BioXcel Therapeutics
BTAI
$55.2M
$281K 0.15%
405
-56
-12% -$38.9K
YMAB icon
238
Y-mAbs Therapeutics
YMAB
$390M
$281K 0.15%
7,309
-1,000
-12% -$38.4K
TBIO
239
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$280K 0.15%
20,599
-2,796
-12% -$38K
FCT
240
First Trust Senior Floating Rate Income Fund II
FCT
$263M
$278K 0.15%
25,376
-4,385
-15% -$48K
VVR icon
241
Invesco Senior Income Trust
VVR
$555M
$277K 0.15%
75,800
-24,507
-24% -$89.6K
MEIP icon
242
MEI Pharma
MEIP
$139M
$276K 0.14%
4,416
-602
-12% -$37.6K
PRVB
243
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$276K 0.14%
21,485
-2,916
-12% -$37.5K
DRNA
244
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$276K 0.14%
15,364
-2,097
-12% -$37.7K
DCF
245
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$276K 0.14%
34,358
-11,769
-26% -$94.5K
WVE icon
246
Wave Life Sciences
WVE
$1.32B
$272K 0.14%
32,016
-4,345
-12% -$36.9K
VYGR icon
247
Voyager Therapeutics
VYGR
$235M
$271K 0.14%
25,411
-3,463
-12% -$36.9K
BDTX icon
248
Black Diamond Therapeutics
BDTX
$167M
$270K 0.14%
8,920
-1,214
-12% -$36.7K
BGT icon
249
BlackRock Floating Rate Income Trust
BGT
$317M
$269K 0.14%
23,969
-5,109
-18% -$57.3K
SGMO icon
250
Sangamo Therapeutics
SGMO
$165M
$265K 0.14%
28,049
-3,815
-12% -$36K